Cover Image

Hemodynamic effects of sacubitril/valsartan in patients with reduced left ventricular ejection fraction over 24 months: a retrospective study

The effects of sacubitril/valsartan in patients with chronic heart failure with reduced ejection fraction (HFrEF) were recently reported. However, the hemodynamic impact of this well-established treatment in patients with HFrEF has been poorly systematically researched.

Saved in:
Bibliographic Details
Main Authors: Abumayyaleh, Mohammad S. A. (Author) , Demmer, Jonathan (Author) , Krack, Carina (Author) , Pilsinger, Christina (Author) , El-Battrawy, Ibrahim (Author) , Behnes, Michael (Author) , Aweimer, Assem (Author) , Mügge, Andreas (Author) , Lang, Siegfried (Author) , Akın, Ibrahim (Author)
Format: Article (Journal)
Language:English
Published: 30 March 2022
In: American journal of cardiovascular drugs
Year: 2022, Volume: 22, Issue: 5, Pages: 535-544
ISSN:1179-187X
DOI:10.1007/s40256-022-00525-w
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s40256-022-00525-w
Verlag, kostenfrei, Volltext: https://link.springer.com/content/pdf/10.1007/s40256-022-00525-w.pdf?pdf=button
Get full text
Author Notes:Mohammad Abumayyaleh, Jonathan Demmer, Carina Krack, Christina Pilsinger, Ibrahim El-Battrawy, Michael Behnes, Assem Aweimer, Andreas Mügge, Siegfried Lang, Ibrahim Akin
Description
Summary:The effects of sacubitril/valsartan in patients with chronic heart failure with reduced ejection fraction (HFrEF) were recently reported. However, the hemodynamic impact of this well-established treatment in patients with HFrEF has been poorly systematically researched.
Item Description:Gesehen am 18.09.2023
Physical Description:Online Resource
ISSN:1179-187X
DOI:10.1007/s40256-022-00525-w

Similar Items